ANUHPHR Share Price Target 2040

CAGR-based price projection for Anuh Pharma Limited (ANUHPHR) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (3.1% CAGR)
Rs 131
2040 Target
Base Case (7.6% CAGR)
Rs 241
2040 Target
Bull Case (20.6% CAGR)
Rs 1,189
2040 Target

Current Market Snapshot

CMP: Rs 85.85
52W High: Rs 96.74
52W Low: Rs 75.53
1Y CAGR: 15.9%
3Y CAGR: 7.6%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 88 Rs 92 Rs 104
2028 Rs 91 Rs 99 Rs 125
2029 Rs 94 Rs 107 Rs 151
2030 Rs 97 Rs 115 Rs 182
2031 Rs 100 Rs 124 Rs 219
2032 Rs 103 Rs 134 Rs 265
2033 Rs 106 Rs 144 Rs 319
2034 Rs 109 Rs 155 Rs 385
2035 Rs 113 Rs 167 Rs 465
2036 Rs 116 Rs 179 Rs 561
2037 Rs 120 Rs 193 Rs 677
2038 Rs 123 Rs 208 Rs 817
2039 Rs 127 Rs 224 Rs 985
2040 Rs 131 Rs 241 Rs 1,189

Other ANUHPHR Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the ANUHPHR share price target for 2040?

Based on historical growth analysis, the ANUHPHR share price target for 2040 ranges from Rs 131 (conservative) to Rs 241 (base case) to Rs 1,189 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of ANUHPHR?

The current market price of ANUHPHR (Anuh Pharma Limited) is Rs 85.85. The 52-week high is Rs 96.74 and 52-week low is Rs 75.53.

Is ANUHPHR a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for ANUHPHR price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 3.1% CAGR), Base (7.6% CAGR), and Bull (optimistic at 20.6% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.